Dedicated to the public good, Knoa Pharma will deliver billions of dollars of value to communities across the country affected by the opioid crisis
Knoa Pharma will apply its scientific expertise to develop and distribute opioid addiction treatment and overdose reversal medicines
Knoa Pharma will operate in a responsible and sustainable manner, taking into account long-term public health interests related to the opioid crisis
STAMFORD, Conn.--(BUSINESS WIRE)--Following the United States Bankruptcy Court approval of the Purdue Pharma L.P. chapter 11 plan of reorganization (the “Plan”), the name of the new company that will emerge was announced: Knoa Pharma LLC (pronounced “No-ah”). The name was selected by the Company’s creditors.
“The creditors’ selection of this strong name is a tangible sign that this long bankruptcy process is coming to a productive conclusion where the fighting can end and the flow of funds can begin.”
Tweet this
“With a confirmed Plan under which Purdue will fade away, and a corporate identity for the new company that will receive its assets, we are another step closer to delivering billions of dollars of value to communities across the country to help address and abate the opioid crisis,” said Purdue Board Chairman Steve Miller. “The creditors’ selection of this strong name is a tangible sign that this long bankruptcy process is coming to a productive conclusion where the fighting can end and the flow of funds can begin.”
The name connotes knowledge...
Read Full Story: https://www.businesswire.com/news/home/20210903005441/en/Confirmed-Plan-of-Reorganization-of-Purdue-Pharma-L.P.-Facilitates-Creation-of-New-Company-%E2%80%93-%E2%80%9CKnoa-Pharma%E2%80%9D
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.